Similar But Not Identical: Plaque Psoriasis Exacerbation in a Patient With Crohn’s Disease After Switching From CT-P13 to SB2 Infliximab Biosimilar
Author(s) -
Cristiano Pagnini,
M.C. Di Paolo,
Giulia De Angelis,
Federica Torcolacci,
Michele Milano,
Daniela Trinca,
Roberto Porciello,
Maria Giovanna Graziani
Publication year - 2020
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izaa128
Subject(s) - biosimilar , infliximab , medicine , plaque psoriasis , exacerbation , crohn's disease , inflammatory bowel disease , psoriasis , disease , dermatology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom